In their 2003 paper, Jacobs et al. studied the clinical benefit of the administration of exogenous EPO for critically ill infants with bronchiolitis.50 EPO showed no difference in improvement when administered, quantified as the need for transfusions, between the two groups. This evidence concerns the gene EPO and bronchiolitis.